Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prager

Showing results (31-40 of 2,413) with videos related to

Pageof 242
Sort By:
Der Radiologe|February 1, 1976
[Orbital changes in neurofibromatosis (author's transl)]P J Prager
International Anesthesiology Clinics|January 1, 1991
Care of organ donorsM C Prager
Seminars in Cell & Developmental Biology|June 20, 2017
Mechanosensing in hypothalamic osmosensory neuronsMasha Prager-Khoutorsky
European Journal of Dermatology : EJD|October 27, 2010
A prospective, rater-blind, randomized comparison of the effectiveness and tolerability of Belotero ® Basic versus Restylane ® for correction of nasolabial foldsWelf Prager, Volker Steinkraus
Journal of Leukocyte Biology|May 21, 2019
Mechanisms of natural killer cell-mediated cellular cytotoxicityIsabel Prager, Carsten Watzl
Indian Journal of Pediatrics|March 6, 2007
Magnetic resonance imaging of the neonatal brainAriel Prager, Sudipta Roychowdhury
Leukemia & Lymphoma|August 1, 1997
Transactivation of the interleukin-1 alpha promoter by human T-cell leukemia virusN Mori, D Prager
Journal of Personality and Social Psychology|November 22, 2021
Forming impressions from self-truncated samples of traits-interplay of Thurstonian and Brunswikian sampling effectsJohannes Prager, Klaus Fiedler
Cancer Research|February 15, 1996
High levels of AP-2-binding activity in cell lines infected with human T-cell leukemia virus type I: possible enhancement of AP-2 binding by human T-cell leukemia virus type I taxN Mori, D Prager
Journal of Cosmetic Dermatology|November 24, 2012
Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown linesWelf Prager, Thomas Rappl
Pageof 242

Showing results (31-40 of 2,413) with videos related to

Sort By:
Pageof 242
Der Radiologe|February 1, 1976
[Orbital changes in neurofibromatosis (author's transl)]P J Prager
International Anesthesiology Clinics|January 1, 1991
Care of organ donorsM C Prager
Seminars in Cell & Developmental Biology|June 20, 2017
Mechanosensing in hypothalamic osmosensory neuronsMasha Prager-Khoutorsky
European Journal of Dermatology : EJD|October 27, 2010
A prospective, rater-blind, randomized comparison of the effectiveness and tolerability of Belotero ® Basic versus Restylane ® for correction of nasolabial foldsWelf Prager, Volker Steinkraus
Journal of Leukocyte Biology|May 21, 2019
Mechanisms of natural killer cell-mediated cellular cytotoxicityIsabel Prager, Carsten Watzl
Indian Journal of Pediatrics|March 6, 2007
Magnetic resonance imaging of the neonatal brainAriel Prager, Sudipta Roychowdhury
Leukemia & Lymphoma|August 1, 1997
Transactivation of the interleukin-1 alpha promoter by human T-cell leukemia virusN Mori, D Prager
Journal of Personality and Social Psychology|November 22, 2021
Forming impressions from self-truncated samples of traits-interplay of Thurstonian and Brunswikian sampling effectsJohannes Prager, Klaus Fiedler
Cancer Research|February 15, 1996
High levels of AP-2-binding activity in cell lines infected with human T-cell leukemia virus type I: possible enhancement of AP-2 binding by human T-cell leukemia virus type I taxN Mori, D Prager
Journal of Cosmetic Dermatology|November 24, 2012
Phase IV study comparing incobotulinumtoxinA and onabotulinumtoxinA using a 1:1.5 dose-conversion ratio for the treatment of glabellar frown linesWelf Prager, Thomas Rappl
Pageof 242